ORI
GILD icon

Oak Ridge Investments’s Gilead Sciences GILD Stock Holding History

Oak Ridge Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-85,509
Closed -$6.05M – 164
2017
Q2 		$6.05M Buy
85,509
+4,284
+5% +$285K 0.19% 105
2017
Q1 		$5.52M Buy
81,225
+14,441
+22% +$1.02M 0.19% 100
2016
Q4 		$4.78M Sell
66,784
-47,035
-41% -$3.5M 0.16% 101
2016
Q3 		$9.01M Sell
113,819
-1,754
-2% -$142K 0.23% 91
2016
Q2 		$9.64M Sell
115,573
-6,636
-5% -$589K 0.25% 94
2016
Q1 		$11.2M Sell
122,209
-1,046
-0.8% -$94.3K 0.28% 88
2015
Q4 		$12.5M Buy
123,255
+431
+0.4% +$44.8K 0.3% 85
2015
Q3 		$12.1M Sell
122,824
-86,309
-41% -$9.59M 0.29% 88
2015
Q2 		$24.5M Buy
209,133
+573
+0.3% +$62.6K 0.52% 58
2015
Q1 		$20.5M Buy
208,560
+47,968
+30% +$4.87M 0.46% 67
2014
Q4 		$15.1M Sell
160,592
-5,580
-3% -$577K 0.36% 74
2014
Q3 		$17.7M Sell
166,172
-4,920
-3% -$482K 0.46% 69
2014
Q2 		$14.3M Buy
171,092
+13,080
+8% +$1.02M 0.34% 85
2014
Q1 		$11.2M Sell
158,012
-95,855
-38% -$7.52M 0.28% 92
2013
Q4 		$19.1M Sell
253,867
-7,292
-3% -$508K 0.5% 65
2013
Q3 		$16.4M Sell
261,159
-2,931
-1% -$175K 0.45% 67
2013
Q2 		$13.5M Buy
+264,090
New +$13.8M 0.42% 71

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oak Ridge Investments's GILD Position: Q3 2017 in Review

Oak Ridge Investments sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 85,509 shares — an estimated $6.05M sold.

Oak Ridge Investments first reported a position in GILD in Q2 2013 and held it in 17 quarters. The position peaked at $24.5M in Q2 2015. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Oak Ridge Investments reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Oak Ridge Investments sold 85,509 Gilead Sciences shares in Q3 2017, an estimated $6.05M.
  • Oak Ridge Investments first reported a position in Gilead Sciences in Q2 2013 and held it in 17 quarters.
  • Oak Ridge Investments's Gilead Sciences position peaked at $24.5M in Q2 2015.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Oak Ridge Investments's 13F filing for Q3 2017, filed 7 Nov 2017.